RVNC expects 2015 cash burn of $74-84M (up from range of $69-71M in 2014): http://finance.yahoo.com/news/revance-therapeutics-defines-clinical-program-120000458.html It’s a little silly that there's a $2M-wide interval for 2014 cash burn at this late date, but that’s what the PR says.